Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-033534
Filing Date
2025-03-05
Accepted
2025-03-05 16:05:24
Documents
1
Period of Report
2025-03-03

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3619
  Complete submission text file 0000950170-25-033534.txt   5163
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Issuer) CIK: 0001653087 (see all company filings)

EIN.: 822933343 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ALECTOR, INC 131 OYSTER POINT BLVD, SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address
Kenkare-Mitra Sara (Reporting) CIK: 0001895592 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38792 | Film No.: 25710900